Journal article

Phase I trial of the farnesyl protein transferase (FPTASE) inhibitor L-778123 in combination with radiotherapy

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Hahn, S., Kiel, K., Morrison, B., Mohiuddin, M., Delaney, T., Smith, D., Brown, R., Pramanik, B., Deutsch, P., Bernhard, E., Muschel, R., & McKenna, G. (2000). Phase I trial of the farnesyl protein transferase (FPTASE) inhibitor L-778123 in combination with radiotherapy. CLINICAL CANCER RESEARCH, 6, 4481S–4481S.

MLA Style

Hahn, S, et al. “Phase I Trial of the Farnesyl Protein Transferase (FPTASE) Inhibitor L-778123 in Combination with Radiotherapy.” CLINICAL CANCER RESEARCH, vol. 6, 2000, pp. 4481S–4481S.

Chicago Style

Hahn, S, K Kiel, B Morrison, et al. 2000. “Phase I Trial of the Farnesyl Protein Transferase (FPTASE) Inhibitor L-778123 in Combination with Radiotherapy.” CLINICAL CANCER RESEARCH 6: 4481S–4481S.
Print

Authors

+ Hahn, S More by this author

Role:: Author

+ Kiel, K More by this author

Role:: Author

+ Morrison, B More by this author

Role:: Author

+ Mohiuddin, M More by this author

Role:: Author

+ Delaney, T More by this author

Role:: Author

More authors...

Journal:: CLINICAL CANCER RESEARCH More from this journal
Volume:: 6
Pages:: 4481S-4481S
Publication date:: 2000-11-01
ISSN:: 1078-0432

Pubs id:: pubs:223363
UUID:: uuid:12b8dda1-ef3c-464e-9882-e5b498326598
Local pid:: pubs:223363
Source identifiers:: 223363
Deposit date:: 2012-12-19
ARK identifier:: ark:/29072/ora_12b8dda1ef3c464e9882e5b498326598

Terms of use

Copyright date:: 2000

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP